drugset / Trial / NCT02137928

Carboplatin Periocular Injection for Retinoblastoma

NCT02137928 ↗

Phase 3 Unknown 50 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the clinical efficacy of periocular injections of carboplatin together with chemotherapy in the treatment of Retinoblastoma as compared to chemotherapy alone.

Timeline

Start
2006-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 20 mg Other
Subject Carboplatin Small molecule 560 mg/m2 Other
Comparator Etoposide Small molecule 150 mg/m2 —
Comparator Vincristine Small molecule 1.5 mg/m2 —

Indications